Cardio Diagnostics Holdings, Inc. financial data

Symbol
CDIO, CDIOW on Nasdaq
Location
311 W. Superior Street, Suite 444, Chicago, IL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.66K % +570%
Debt-to-equity 9.99 % -84.7%
Return On Equity -72.8 % +76.4%
Return On Assets -66.2 % +64.6%
Operating Margin -32K % -48.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.76M shares -92.6%
Common Stock, Shares, Outstanding 1.74M shares -92.5%
Entity Public Float 10.7M USD +13.8%
Common Stock, Value, Issued 17 USD -92.7%
Weighted Average Number of Shares Outstanding, Basic 1.74M shares +131%
Weighted Average Number of Shares Outstanding, Diluted 1.74M shares +131%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 19.5K USD -50.2%
Research and Development Expense 176K USD +174%
Selling and Marketing Expense 190K USD +32.4%
General and Administrative Expense 5.59M USD -41.2%
Operating Income (Loss) -6.23M USD +26%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.25M USD +28.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -6.25M USD +28.8%
Earnings Per Share, Basic 5 USD/shares +43.3%
Earnings Per Share, Diluted 5 USD/shares +43.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 0 USD
Accounts Receivable, after Allowance for Credit Loss, Current 12.9K USD +71.9%
Assets, Current 8.7M USD +307%
Property, Plant and Equipment, Net 622K USD -13.6%
Operating Lease, Right-of-Use Asset 347K USD -32.6%
Assets 10.4M USD +160%
Liabilities, Current 370K USD -1.73%
Operating Lease, Liability, Noncurrent 302K USD -44.7%
Liabilities 672K USD -27.2%
Retained Earnings (Accumulated Deficit) -26.1M USD -31.5%
Stockholders' Equity Attributable to Parent 9.72M USD +216%
Liabilities and Equity 10.4M USD +160%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.4M USD -13.5%
Net Cash Provided by (Used in) Financing Activities 3.31M USD +109%
Net Cash Provided by (Used in) Investing Activities -47.4K USD +32.2%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 1.74M shares -92.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.97M USD +508%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.69K USD -19.4%
Deferred Tax Assets, Valuation Allowance 5.61M USD +32.7%
Deferred Tax Assets, Gross 5.61M USD +32.7%
Operating Lease, Liability 605K USD -27.3%
Depreciation 150K USD +245%
Payments to Acquire Property, Plant, and Equipment 5.79K USD -71%
Lessee, Operating Lease, Liability, to be Paid 577K USD -31%
Operating Lease, Liability, Current 244K USD +5.93%
Lessee, Operating Lease, Liability, to be Paid, Year Two 250K USD -4.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 131K USD +1.21%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 36.5K USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three 102K USD -59.2%
Deferred Tax Assets, Operating Loss Carryforwards 5.58M USD +32.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 93.6K USD -8.33%
Operating Lease, Payments 64.8K USD +1.2%
Additional Paid in Capital 35.8M USD +56.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 13.3K USD -16.7%
Interest Expense 16.4K USD -19.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%